Company / Free Cash Flow per Share
AbCellera Biologics Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.59
FY2025
5-year range
-$0.64 / $0.05
FY2021-FY2025
Trend
+8.4%
vs FY2024
Sector context
#93 of 192
Health Care
What the data says
At $-0.59, AbCellera Biologics Inc.'s free cash flow per share ranks #93 of 192 in the Health Care sector. Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.59.
Based on SEC 10-K filings.
-0.59 in FY2025.
Declined from $-0.42 to $-0.59 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 192 in Health CareTop 48% of 192This company -$0.59 Sector average $3.32
▼
-117.7% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 8.4% year-over-year.
- Ranks #93 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2020.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.59 | +8.4% |
| FY2024 | -$0.64 | -52.6% |
| FY2023 | -$0.42 | -1016.6% |
| FY2022 | $0.05 | +1050.5% |
| FY2021 | -$0.00 | -109.8% |
| FY2020 | $0.05 | +674.5% |
| FY2019 | -$0.01 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026